Utility-Based Optimization of Combination Therapy Using Ordinal Toxicity and Efficacy in Phase I/II Trials (Q3576931): Difference between revisions
From MaRDI portal
Created a new Item |
Created claim: Wikidata QID (P12): Q33945668, #quickstatements; #temporary_batch_1711439739529 |
||
(3 intermediate revisions by 3 users not shown) | |||
Property / MaRDI profile type | |||
Property / MaRDI profile type: MaRDI publication profile / rank | |||
Normal rank | |||
Property / OpenAlex ID | |||
Property / OpenAlex ID: W2050950840 / rank | |||
Normal rank | |||
Property / Wikidata QID | |||
Property / Wikidata QID: Q33945668 / rank | |||
Normal rank | |||
links / mardi / name | links / mardi / name | ||
Revision as of 19:53, 26 March 2024
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Utility-Based Optimization of Combination Therapy Using Ordinal Toxicity and Efficacy in Phase I/II Trials |
scientific article |
Statements
Utility-Based Optimization of Combination Therapy Using Ordinal Toxicity and Efficacy in Phase I/II Trials (English)
0 references
3 August 2010
0 references
adaptive design
0 references
Bayesian design
0 references
clinical trial
0 references
combination dose finding
0 references
utility
0 references